Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy.
about
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites.Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience.Emerging treatment options for management of malignant ascites in patients with ovarian cancer.Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo.Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.
P2860
Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Treatment and prevention of ma ...... ive combined-modality therapy.
@ast
Treatment and prevention of ma ...... ive combined-modality therapy.
@en
type
label
Treatment and prevention of ma ...... ive combined-modality therapy.
@ast
Treatment and prevention of ma ...... ive combined-modality therapy.
@en
prefLabel
Treatment and prevention of ma ...... ive combined-modality therapy.
@ast
Treatment and prevention of ma ...... ive combined-modality therapy.
@en
P2093
P1433
P1476
Treatment and prevention of ma ...... sive combined-modality therapy
@en
P2093
P304
P577
1997-02-01T00:00:00Z